News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
News Conference News ACC 2023 Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR Michael O'Riordan March 13, 2023
News Conference News CRT 2023 In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’ Yael L. Maxwell March 01, 2023
News Conference News TCT 2022 Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients Yael L. Maxwell September 27, 2022
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News TCT 2021 ‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients Yael L. Maxwell November 04, 2021
News Conference News ESC 2020 In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD Yael L. Maxwell September 01, 2020
News Conference News ESC 2019 Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS Michael O'Riordan September 01, 2019
News Conference News AHA 2018 Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI Michael O'Riordan November 14, 2018
News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Conference News EuroPCR 2017 BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI Michael O'Riordan May 18, 2017
News Conference News COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions Jason Kahn November 30, 2011
News Conference News RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority August 31, 2011